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1. Introduction
  There are 1.2 million heart surgery around the world 
every year, as the statistics showed[1-3]. The prevention and 
control of postoperative complications of cardiac surgery 
has gained extensive clinical attention. Studies have shown 
that[4,5], postoperative gastrointestinal complications of 
heart surgery are 0.5% to 4.0%, with main symptoms of 
perforation, ischemic enteritis and gastrointestinal bleeding 
etc, which can be as high as 26%-75% mortality rate. How to 
reduce the incidence of gastrointestinal complications after 
heart surgery has become urgent. CPB perfusion should 
first guarantee important organs, thus it can easily lead to 
decreased gastrointestinal mucosal blood flow, induces 
intestinal ischemia-reperfusion injury[6-8]. At present, 
clinical protection against intestinal ischemia-reperfusion 
injury during CPB after heart surgery is mainly by way of 
inhibiting gastric acid, but excessive inhibition of gastric 
acid can lead to intestinal micro environmental damage, 
and bacterial translocation, with a poor effect[9]. Therefore, 
seeking a better way to protect intestinal mucosa during 
CPB is particularly important. Studies have confirmed 
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that[10], emodin can reduce the inflammatory reaction, and 
have significant protective effect on the intestinal ischemia-
reperfusion injury (I-RI). To observe protective effects and 
mechanism of emodin on intestinal I-RI, we selected SD rat 
intestinal I-RI model, the results are reported as follows.
2. Materials and methods
2.1.Experimental animals 
  A total of 50 healthy adult SD rats, male and female 
unlimited, weight 250-300 g, clean level, were provided 
by our animal experiment center. They were provided with 
free food and water, adaptive feed for 5 d, before modeling, 
limited food for 12 h and water for 4 h, the experiment 
process on animals were strictly followed by the regulations 
on the administration of experimental animals. 
2.2. Instrument and reagent 
  Emodin chemical reference substance and sodium 
carboxymethyl cellulose were bought from Beijing Solarbio 
Science and Technology Vo., LTD. Anhydrous calcium 
chloride and 10% chloral hydrate were provided by the 
national medicine group chemical reagent Beijing Vo., LTD.; 
TNF-毩 Elisa kit, endotoxin Elisa kit, IFABP Elisa kit and 
IL-6 Elisa kit were purchased from RD Company, USA; 
DAO, SOD, MDA and MPO reagent plates were purchased 
from Nanjing Institute of Biological Engineering Institute. 
RH-1650 low temperature centrifuge were provided from 
Shanghai Lingcheng Biological Technology Co., LTD.; 
MICROM HM325 tissue slicing machine were provided from 
Zeiz Company, Germany; BH-2 optical microscope were 
provided from Olympus Company, Japan.
2.3. Model establishment 
  Intraperitoneal injection of 10% chloral hydrate was used 
for anesthesia by dose of 3 mL/kg. They were fixed in 
supine position. After disinfection, incision laparotomy was 
performed along epigastric midline, and the root of superior 
mesenteric artery was separated by blunt separation. Blood 
flow was blocked by using noninvasive clip at mesenteric 
artery root, the wounds were sutured. Under light, the artery 
clip was loosen from the original incision on abdomen to 
restore the blood perfusion 1 h after ischemia, and was 
reperfused for 1 h.
2.4.  Animal grouping
  A total of 50 SD rats were randomly divided into control 
group, model group, emodin groups of low, medium and 
high dose, with 10 in each group. Ischemia-reperfusion 
injury model was established by using noninvasive clamp 
on superior mesentericartery (SMA), the separation of the 
superior mesenteric artery root no arterial clip operation 
was performed in control group after laparotomy. In Control 
group and model group they were pretreated with 0.5% 
sodium carboxymethyl cellulose solution 1 mL/100 g lavage 
2 h before operation, while in emodin groups of low, medium 
and high dose they were given emodin lavage with 20, 40, 
60 mg/kg pretreatment. In emodin lavage preparation, the 
corresponding dose of emodin was added to 0.5% sodium 
methyl cellulose solution for 1 mL/ 100 g .
2.5. Observation indicators
  2 mL of femoral venous blood before the lavage 
pretreatment (T0) and 1 h ischemia (T1) , and inferior vena 
venous blood after 1 h of reperfusion (T2) were extracted 
from each group of rats, and the centrifugal supernatant was 
saved at - 70 ℃. With double sandwich ELISA method serum 
level of intestinal fatty acid binding protein (I-FABP), tumor 
necrosis factor (TNF-毩), endotoxin, interleukin 6 (IL-6), and 
the content of diamine oxidase (DAO) were detected. After 
modeling, the rats were sacrificed, and 2 cm blind intestinal 
tissue was prepared for saline rinse. They underwent routine 
dehydration, transparent procession, paraffin embedding, 
sectioning and HE staining. Pathological changes were 
observed under optical microscope. Meanwhile, intestine 
homogenate was prepared using blind intestinal tissue 
for detection of intestinal tissue myeloperoxidase (MPO), 
malondialdehyde (MDA) and superoxide dismutase (SOD) 
levels. 
2.6. Statistical analysis
  Data were expressed as mean依sd, and analyzed by t test. 
P<0.05 was regarded as significant difference.
3. Results
3.1. I-FABP, TNF, endotoxin, IL-6 and DAO serum levels
  In emodin groups of low, medium and high dose at T1 and 
T2, I-FABP, TNF-毩, endotoxin, IL-6 and DAO level were 
significantly lower than that of sham group (P<0.05); I- 
FABP, TNF-毩, endotoxin and DAO level were significantly 
lower than that of control group (P<0.05). There was no 
statistical difference in serum I-FABP, TNF-毩, endotoxin, 
IL-6 and DAO levels among emodin group of low, medium 
and high dose at different time points (P>0.05) (Table 1).
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3.2.  MDA, SOD and MPO levels in intestinal homogenate
MPO and MDA in model group and emodin low, medium and 
high dose group were significantly higher than that of control 
group (P<0.05), SOD levels in model group and emodin low, 
medium and high dose groups were significantly lower than 
that in control group (P<0.05); SOD level in emodin low, 
medium and high dose group was significantly higher than 
that of model group (P<0.05) (Table 2). 
3.3. Histological observation
  Microscopically, the control group with normal structure 
of intestinal wall, complete mucous membrane layer and 
epithelial cells, and smooth surface; model group with part 
of intestines mucous membrane layer fell off, disordered 
arranged villus cells in degeneration necrosis, central 
expanded lacteals and lamina propria capillary, a number 
of inflammatory cell in infiltration; emodin low, medium 
and high dose group with similar degree of intestinal tissue 
lesions, significantly lighter than that in model group, the 
intestines mucous membrane layer of fluff were in complete 
structure and order, small amount of epithelial shedding 
on the top was observable, on the villous surface, a small 
amount of inflammatory cells were visible, mild expanded 
central lacteals, with significant degree of pathological 
changes (Figure 1).
Sham group                            Model group                       Low does group
 Medium dose group                                     High dose group
Figure 1. histological changes of rat intestinal mucosa epithelium 
(HE,×200).
4. Discussion
  I-RI refers to pathological process of  cell structure, 
metabolism impairment aggravating when restoring blood 
supply after a period of time ischemia to organs and 
tissues[11]. I-RI pathogenesis is not fully clear, it is thought 
to be related with energy metabolic disorders,  oxygen free 
radicals, inflammatory mediators and enzymes activity and 
content abnormalitie[12-16]. Intestinal organs are the stress 
center for the body, research has confirmed that in the 
stress reaction such as major surgery, trauma, it is easy to 
Table 1
Serum I -FABP, TNF-毩, endotoxin, IL-6 and DAO level (n=10).
Groups I-FABP (ng/L) TNF-毩 (ng/L) endotoxin  (Eu/mL) IL-6 (pg/mL) DAO (U/L)
Sham group T0 17.53依3.34 34.92依9.15 0.051依0.011 25.86依6.90 28.76依9.15
T1 22.98依5.06 38.75依6.34 0.047依0.023 29.30依6.71 31.01依8.82
T2 26.77依10.31 40.88依7.72 0.057依0.016 31.42依6.03 35.75依9.66
Model group T0 16.26依4.31 34.43依12.28 0.049依0.015 25.33依9.02 28.89依7.99
T1 41.84依15.90* 49.76依10.29* 0.070依0.013* 41.07依8.18* 42.38依9.40*
T2 48.64依7.13* 64.01依11.53* 0.072依0.018* 50.05依11.62* 49.06依9.50*
Low does group T0 16.01依3.59 34.61依4.92 0.048依0.012 25.65依8.79 29.55依7.38
T1 27.27依8.05# 43.00依14.53 0.056依0.014 31.00依9.667# 32.20依9.39#
T2 29.79依4.35# 50.78依13.36# 0.061依0.016 36.59依9.57# 37.23依9.96#
Medium dose group T0 17.23依3.07 34.51依5.79 0.049依0.009 25.03依7.21 28.48依5.51
T1 25.97依6.81# 38.23依7.80# 0.052依0.008# 30.73依7.44# 31.87依5.71#
T2 32.29依7.50# 45.93依6.36# 0.056依0.011# 37.51依8.72# 36.89依8.88#
High dose group T0 16.91依3.23 33.65依4.70 0.051依0.011 24.78依6.93 28.30依6.30
T1 26.07依8.09# 39.63依4.84# 0.053依0.011# 32.85依7.93 33.92依7.77
T2 32.03依9.51# 48.72依6.97# 0.059依0.015 38.75依9.02# 38.28依9.07
Note: # P<0.05 compared with model group, *P<0.05 compared with control group.
Table 2
MDA, SOD and MPO level comparison among groups (n=10).
Groups MPO (U/g) MDA (nmol/mgprot) SOD (U/mgprot)
Sham group 0.15依0.06 1.36依0.41  98.14依15.39
Model group 0.30依0.06  3.09依0.98* 60.33依8.57*
Low does group  0.20依0.10#  1.87依0.72# 85.27依15.98#
Medium dose group  0.20依0.07#  1.92依0.94# 82.29依16.91#
High dose group  0.20依0.07#  2.01依0.86#   79.23依10.80*#
Note: # P<0.05 compared with model group, *P<0.05 compared with control group.
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cause damage of intestinal mucosa[17]. I-RI is a pathological 
process induced by many diseases, causing damage of 
intestinal mucosa, and translocation of intestinal endotoxin 
and bacterial, which induces severe complications like 
systemic inflammatory response syndrome and multiple 
organ dysfunction syndrome[18]. At present, the western 
medicine in clinical treatment of prevention and treatment 
for intestinal mucosa barrier damage has not gained 
much breakthrough, so many scholars are studying on 
traditional Chinese medicine, and have obtained remarkable 
achievements.
  Emodin is the effective component extracted from many 
traditional Chinese medicines, can reduce the TNF alpha, 
the release of NO and the production of oxygen free 
radicals, and can reduce the activation of neutrophils, thus 
inhibiting excessive inflammation, and protecting against 
ischemia-reperfusion injury[19]. Modern pharmacology study 
showed that[20], emodin can improve the blood circulation, 
promote intestinal peristalsis, reduce the permeability 
of intestinal mucosa, regulate immune function, anti-
inflammation, killing microbes etc, play a significant role 
on protecting intestinal mucosa[21-23]. I-FABP protein in 
cells has the specific antigen host, expression is confined 
to small intestine membrane cells and gastric membrane. 
Studies have confirmed that[24], in the early stage of small 
intestine ischemia, I-FABP levels increased, after resection 
the necrosis intestinal part, I-FABP level returned to 
normal, the level change were positively correlated with 
gastrointestinal injury severity. In this study, I-FABP 
concentration of model group was significantly increased 
after T1, and even higher after T2, while serum I-FABP 
concentration in emodin low, medium and high dose group 
at T1 and T2 was significantly lower than that of model group 
(P>0.05), suggesting that emodin has certain protective effect 
on intestinal wall after intestinal ischemia-reperfusion 
injury. TNF-毩 is activated by soluble polypeptide secreted 
by neutrophils and endothelial cells, is also an important 
inflammatory mediators, widely participating in the body 
inflammatory response. When I-RI happens, mononuclear 
and macrophages are excessively activated and lead to 
higher expression of TNF-毩 mRNA, causing increased 
inflammatory mediator release and intestinal tissue 
damage[25]. Emodin low, medium and high dose group, 
according to the results of this study, had a significantly 
lower serum TNF level after T1, T2 than that of model 
group (P<0.05), suggesting emodin can restrain bowel I-RI 
after the release of TNF-毩, so as to reduce the damage 
of intestinal mucosa. Endotoxin, its chemical nature is 
lipopolysaccharide, in the case of intestinal barrier function 
complete, endotoxin seldomly enter blood circulation, when 
the intestinal barrier function is impaired, endotoxin can 
pass through the intestinal mucosa into the blood, and its 
content can reflect the intestinal mucosal barrier function 
and intestinal I-RI prognosis[26]. In this study, the endotoxin 
levels in model group after T1, T2 increased significantly 
than that in control group (P<0.05); endotoxin levels in 
emodin low, medium and high dose groups at T1 and T2 
were significantly lower than that of model group (P<0.05), 
suggesting emodin is good for maintaining integrity of 
intestinal mucosal barrier function. IL-6 can promote the 
production of inflammatory cytokines, increase immunity 
and inflammation strength, is an early sensitive indicators 
reflect the tissue damage[27]. Emodin low, medium and high 
dose group in this study, serum level of IL-6 after T1, T2 
was significantly lower than that of model group (P<0.05), 
indicating that emodin has certain inhibitory effect, can 
reduce intestinal I-RI inflammatory reaction, thus protect 
the intestinal mucosal barrier function. DAO mainly 
distributes on the top of the villus, its active is closely 
related to the mucosal cells of nucleic acid and protein 
synthesis, abnormal activity can reflect the damage degree 
of intestinal barrier immediately[19]. In this study, DAO 
level in model group after T1, T2 was significantly higher 
(P<0.05), indicating that after I-RI, intestinal mucosa barrier 
damage was serious; DAO level in emodin low, medium and 
high dose groups after T1, T2 was significantly lower than 
that of model group (P<0.05), also confirmed that emodin 
pretreatment, can obviously reduce the intestinal mucosa 
barrier damage after I-RI.
  MPO is reliable index of evaluatinge the degree of 
neutrophil infiltration, its excessive activation cause 
the intestinal tissue I-RI by mediating a variety of 
mechanisms[12]. After intestinal I-RI, MDA content made 
of lipid peroxide decomposition can reflect the degree of 
oxygen free radical on tissue and cell damage, and SOD is 
recognized as oxygen free radical scavenger, its vitality can 
indirectly reflect the oxygen free radical scavenging ability 
of the body[13]. Studies have confirmed that[21], emodin can 
improve the cell membrane fluidity, calcium pump activity, 
reduce oxygen free radicals and reduce damage of important 
organs. MPO and MDA content in the emodin low, medium 
and high dose groups was significantly lower than that in 
model group (P<0.05), while SOD activity was significantly 
higher than that of model group (P<0.05), indicating that 
emodin in intestinal I-RI has certain inhibitory effect on 
inflammatory reaction and can maintain the SOD activity, 
thus plays a role of protection of intestinal mucosa barrier 
in I-RI. Histological observation showed that intestinal 
mucosa damage degree of emodin intervention groups were 
significantly lighter than that of model group, also shows 
that emodin has significant protective effect on I-RI damage 
of intestinal mucosain rats.
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